Immunologic production of antiangiotensin. I. Preparation of angiotensin-protein complex antigen.
Angiotensin II was coupled with bovine gamma-globulin (BGG) through the following series of reactions. See PDF for Structure By determinations of the aromatic amine and tyrosine contents of p-aminobenzoylangiotensin II, the number of p-aminobenzoyl residues introduced per molecule of angiotensin II was calculated. Absorption spectra (between 250 and 500 mmicro) of BGG complexes of p-aminobenzoylangiotensin II and six different para substituted aromatic amines were compared. Specific activities (dog units/millimicromole) of the different intermediate products were determined. Presence of a terminal, free amino group does not appear to be an absolute requirement for the biological activity of angiotensin II, since substitution of a p-aminobenzoyl radical in this group yields a product with 40 to 50 per cent of the activity of the parent compound. Angiotensin I, on the other hand, is completely inactivated under identical circumstances. Possible implication of this finding has been discussed.
D000588:Amines; D000802:Angiotensin Amide / Q000037:antagonists & inhibitors*; D000804:Angiotensin II; D000809:Angiotensins; D000818:Animals; D002417:Cattle; D004285:Dogs; D011506:Proteins / Q000737:chemistry*; D014443:Tyrosine
D000588:Amines; D000809:Angiotensins; D011506:Proteins; D000804:Angiotensin II; D014443:Tyrosine; D000802:Angiotensin Amide
HYPERTENSIN/antagonists; PROTEINS/chemistry